Le DRESS syndrome secondaire aux antituberculeux: à propos d’un cas

Jridi, S.; Azzeddine, Rajae; Bourkadi, Jamal Eddine

doi:10.11604/pamj.2017.27.37.11663

Cited by 4 publications

(3 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Rifampicin and isoniazid appear to be the most frequently involved molecules, having been identified as the culprit agent in 19 cases (our case 1, and 18 cases in Supporting Information Table S1 and 18 cases (our cases 1 and 2, and 16 cases in Supporting Information Table S1, respectively. This equally applies to tuberculosis patients concomitantly infected with human immunodeficiency virus (HIV) .…”

Section: Discussionmentioning

confidence: 75%

“…Ethambutol produced a positive skin test reaction in only three cases (our case 1, and two cases in Supporting Information Table S1), gave a negative skin test result in two patients (Supporting Information Table S1), and was responsible for a doubtful skin test result in our case 2. Ten other patients showed reactions when rechallenged with ethambutol (Supporting Information Table S1). When ethambutol is implicated, it is usually responsible for the drug reaction together with one or more other first‐line antituberculosis drugs.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome caused by first‐line antituberculosis drugs: Two case reports and a review of the literature

et al. 2019

View full text Add to dashboard Cite

Background: Patients suffering from drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome caused by first-line antituberculosis drugs often need to be retreated rapidly. Patch tests prior to the reintroduction of antituberculosis drugs are rarely performed.Objectives: To highlight those drugs most often involved in DRESS caused by antituberculosis drugs, illustrate the potential value of patch tests to identify these culprit(s), and provide insights into how to rapidly retreat these patients.Methods: A detailed description of the work-up of two illustrative patients, together with a literature review of similar cases, is provided.

show abstract

Section: Discussionmentioning

confidence: 75%

Section: Discussionmentioning

confidence: 99%

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome caused by first‐line antituberculosis drugs: Two case reports and a review of the literature

et al. 2019

View full text Add to dashboard Cite

show abstract

“…The index case had cutaneous eruptions, eosinophilia, and systemic manifestations (increased liver enzymes > 2 times greater than normal). There are only a few case reports of DRESS syndrome developing after taking ATT which all improved on cessation of therapy [4]. All ATT drugs have been implicated in causing DRESS, with isoniazid and rifampicin being most common [5].…”

mentioning

confidence: 99%

Antitubercular Therapy—An Uncommon Side Effect

Kapur¹,

Gupta²,

Gupta³

et al. 2021

Advances in Respiratory Medicine

View full text Add to dashboard Cite

show abstract

Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review

Sharifzadeh

Mohammadpour

Tavanaee

et al. 2020

Eur J Clin Pharmacol

View full text Add to dashboard Cite

Background Drug reaction with eosinophilia and systemic symptoms syndrome (DRESS) is a delayed infrequent potentially lifethreatening idiosyncratic drug reaction. Aromatic anticonvulsants and allopurinol are the most frequent causative agents. However, various reports of antibiotic-induced DRESS are available. In this review, we try to summarize reports of antibacterial antibiotic-induced DRESS focusing on characteristics of DRESS induced by each antibiotic group. Methods The data were collected by searching PubMed/MEDLINE and ScienceDirect. The keywords used as search terms were "DRESS syndrome," "drug-induced hypersensitivity syndrome (DIHS)," "antibiotics," "antimicrobial," and names of various antimicrobial groups. Finally, 254 relevant cases with a definite or probable diagnosis of DRESS based on RegiSCAR criteria were found until 30 May 2020 and reviewed. Results and conclusion Totally, 254 cases of antibacterial antibiotic-induced DRESS are reported. Most of them are related to antituberculosis drugs, vancomycin, and sulfonamides, respectively. Rash and fever were most frequent clinical findings. Eosinophilia and liver injury were the most reported hematologic and visceral organ involvement, respectively. Most of the patients are managed with systemic corticosteroids. The death occurred in 16 patients which most of them experienced liver or lung involvement. The reactivation of various viruses especially HHV-6 is reported in 33 cases. The mean latency period was 29 days. It is necessary to perform thorough epidemiological, genetic, and immunological studies, also systematic case review and causality assessment, as well as well-designed clinical trials for better management of antibiotic-induced DRESS.

show abstract

Le DRESS syndrome secondaire aux antituberculeux: à propos d’un cas

Cited by 4 publications

References 10 publications

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome caused by first‐line antituberculosis drugs: Two case reports and a review of the literature

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome caused by first‐line antituberculosis drugs: Two case reports and a review of the literature

Antitubercular Therapy—An Uncommon Side Effect

Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review

Contact Info

Product

Resources

About